Journal articles on the topic 'D1-class receptor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'D1-class receptor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Watanabe, Katsushige, and Minoru Kimura. "Dopamine Receptor–Mediated Mechanisms Involved in the Expression of Learned Activity of Primate Striatal Neurons." Journal of Neurophysiology 79, no. 5 (1998): 2568–80. http://dx.doi.org/10.1152/jn.1998.79.5.2568.
Full textIbañez-Sandoval, Osvaldo, Adán Hernández, Benjamin Florán, et al. "Control of the Subthalamic Innervation of Substantia Nigra Pars Reticulata by D1 and D2 Dopamine Receptors." Journal of Neurophysiology 95, no. 3 (2006): 1800–1811. http://dx.doi.org/10.1152/jn.01074.2005.
Full textWang, Chenguang, Nagarajan Pattabiraman, Jian Nian Zhou та ін. "Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation". Molecular and Cellular Biology 23, № 17 (2003): 6159–73. http://dx.doi.org/10.1128/mcb.23.17.6159-6173.2003.
Full textYamamoto, Kei, Olivier Mirabeau, Charlotte Bureau, et al. "Evolution of Dopamine Receptor Genes of the D1 Class in Vertebrates." Molecular Biology and Evolution 30, no. 4 (2012): 833–43. http://dx.doi.org/10.1093/molbev/mss268.
Full textSasikumar, T. K., D. A. Burnett, H. Zhang, A. Smith-Torhan, A. Fawzi, and J. E. Lachowicz. "Hydrazides of clozapine: A new class of D1 dopamine receptor subtype selective antagonists." Bioorganic & Medicinal Chemistry Letters 16, no. 17 (2006): 4543–47. http://dx.doi.org/10.1016/j.bmcl.2006.06.022.
Full textVargo, J. M., B. B. Bromberg, P. J. Best, J. V. Corwin, and J. F. Marshall. "D1-class dopamine receptor involvement in the behavioral recovery from prefrontal cortical injury." Behavioural Brain Research 72, no. 1-2 (1995): 39–48. http://dx.doi.org/10.1016/0166-4328(95)00028-3.
Full textShayegan, Darius K., and Stephen M. Stahl. "Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile." CNS Spectrums 9, S11 (2004): 6–14. http://dx.doi.org/10.1017/s1092852900025086.
Full textSakurai, Atsuko, Julie Gavard, Yuliya Annas-Linhares, et al. "Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras." Molecular and Cellular Biology 30, no. 12 (2010): 3086–98. http://dx.doi.org/10.1128/mcb.01652-09.
Full textPrommer, Eric. "Olanzapine." American Journal of Hospice and Palliative Medicine® 30, no. 1 (2012): 75–82. http://dx.doi.org/10.1177/1049909112441241.
Full textMartini, Michael L., Jing Liu, Caroline Ray, et al. "Defining Structure–Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists." Journal of Medicinal Chemistry 62, no. 7 (2019): 3753–72. http://dx.doi.org/10.1021/acs.jmedchem.9b00351.
Full textTseng, K. Y., L. A. Riquelme, and M. G. Murer. "Impact of d1-class dopamine receptor on striatal processing of cortical input in experimental parkinsonism in vivo." Neuroscience 123, no. 2 (2004): 293–98. http://dx.doi.org/10.1016/j.neuroscience.2003.10.005.
Full textIype, Elizabeth Mathew, Rajan Balakrishna, Lakshmi Subhadradevi, Jissa Vinoda Thulaseedharan, Bharath Veerabadhran, and Jayasree Kattoran. "Expression of proliferation markers in laryngeal squamous cell carcinoma: an association with clinico-pathological factors and treatment outcomes." International Journal of Otorhinolaryngology and Head and Neck Surgery 6, no. 5 (2020): 858. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20201675.
Full textBłaszczak-Świątkiewicz, Katarzyna. "New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity." Molecules 25, no. 6 (2020): 1321. http://dx.doi.org/10.3390/molecules25061321.
Full textAli, Mohamed, Sara Mahmoud Shahin, Nagwa Ali Sabri, Ayman Al-Hendy та Qiwei Yang. "Activation of β-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids". Journal of Clinical Endocrinology & Metabolism 105, № 4 (2019): e1517-e1535. http://dx.doi.org/10.1210/clinem/dgz227.
Full textAmenta, Francesco, Livio Chiandussi, Maurizio Mancini, Alberto Ricci, Marina Schena, and Franco Veglio. "Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex." European Journal of Endocrinology 131, no. 1 (1994): 91–96. http://dx.doi.org/10.1530/eje.0.1310091.
Full textFyfe, Tim J., Peter J. Scammells, J. Robert Lane, and Ben Capuano. "Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D1 Receptor." Molecules 26, no. 13 (2021): 3799. http://dx.doi.org/10.3390/molecules26133799.
Full textBoyle, Kathleen A., and Teresa Compton. "Receptor-Binding Properties of a Soluble Form of Human Cytomegalovirus Glycoprotein B." Journal of Virology 72, no. 3 (1998): 1826–33. http://dx.doi.org/10.1128/jvi.72.3.1826-1833.1998.
Full textOpazo, Juan C., Kattina Zavala, Soledad Miranda-Rottmann, and Roberto Araya. "Evolution of dopamine receptors: phylogenetic evidence suggests a later origin of the DRD2l and DRD4rs dopamine receptor gene lineages." PeerJ 6 (April 13, 2018): e4593. http://dx.doi.org/10.7717/peerj.4593.
Full textSingh-Jasuja, Harpreet, René E. M. Toes, Pieter Spee, et al. "Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis." Journal of Experimental Medicine 191, no. 11 (1999): 1965–74. http://dx.doi.org/10.1084/jem.191.11.1965.
Full textOmeljaniuk, Robert J. "Specific [3H]spiperone binding sites in the pituitary of rainbow trout (Oncorhynchus mykiss) and goldfish (Carassius auratus)." Canadian Journal of Physiology and Pharmacology 73, no. 5 (1995): 585–93. http://dx.doi.org/10.1139/y95-074.
Full textSinnett-Smith, James, Yang Ni, Jia Wang, Ming Ming, Steven H. Young, and Enrique Rozengurt. "Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling." American Journal of Physiology-Cell Physiology 306, no. 10 (2014): C961—C971. http://dx.doi.org/10.1152/ajpcell.00048.2014.
Full textAvila, DM, SA Fuqua, FW George, and MJ McPhaul. "Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment." Journal of Endocrinology 159, no. 3 (1998): 403–11. http://dx.doi.org/10.1677/joe.0.1590403.
Full textSeiler, Max P., Alexander Hagenbach, Hans Juerg Wuethrich, and Rudolf Markstein. "trans-Hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group." Journal of Medicinal Chemistry 34, no. 1 (1991): 303–7. http://dx.doi.org/10.1021/jm00105a047.
Full textTang, Jinhua, Yanli Yan, Ting C. Zhao, George Bayliss, Haidong Yan, and Shougang Zhuang. "Class I histone deacetylase activity is required for proliferation of renal epithelial cells." American Journal of Physiology-Renal Physiology 305, no. 3 (2013): F244—F254. http://dx.doi.org/10.1152/ajprenal.00126.2013.
Full textOrr, Sarah K., Romain A. Colas, Jesmond Dalli, Nan Chiang, and Charles N. Serhan. "Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent." American Journal of Physiology-Lung Cellular and Molecular Physiology 308, no. 9 (2015): L904—L911. http://dx.doi.org/10.1152/ajplung.00370.2014.
Full textSEILER, M. P., A. HAGENBACH, H. J. WUETHRICH, and R. MARKSTEIN. "ChemInform Abstract: trans-Hexahydroindolo(4,3-ab)phenanthridines (“Benzergolines”), the First Structural Class of Potent and Selective Dopamine D1 Receptor Agonists Lacking a Catechol Group." ChemInform 22, no. 24 (2010): no. http://dx.doi.org/10.1002/chin.199124230.
Full textMitrofanova, L. B., A. A. Perminova, N. S. Goncharova, and E. N. Mikhailov. "Histological and immunohistochemical study of nerve fibers and ganglia in the periarterial adipose tissue of the pulmonary artery bifurcation in patients with and without pulmonary hypertension." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 25, no. 5 (2020): 498–509. http://dx.doi.org/10.18705/1607-419x-2019-25-5-498-509.
Full textYang, Quan-en, Andrew G. Stephen, Joseph W. Adelsberger, et al. "Discovery of Small-Molecule Human Immunodeficiency Virus Type 1 Entry Inhibitors That Target the gp120-Binding Domain of CD4." Journal of Virology 79, no. 10 (2005): 6122–33. http://dx.doi.org/10.1128/jvi.79.10.6122-6133.2005.
Full textMackay, Simon P., and Patrick J. O’Malley. "Molecular Modelling of the Interaction of Cyanoacrylate Inhibitors with Photosystem II Part 1. The Effect of Hydrophobicity of Inhibitor Binding." Zeitschrift für Naturforschung C 48, no. 9-10 (1993): 773–81. http://dx.doi.org/10.1515/znc-1993-9-1015.
Full textLewis, C. A., and D. S. Faber. "Properties of spontaneous inhibitory synaptic currents in cultured rat spinal cord and medullary neurons." Journal of Neurophysiology 76, no. 1 (1996): 448–60. http://dx.doi.org/10.1152/jn.1996.76.1.448.
Full textThompson, Peter, Jinhua Lu, and Gerardo G. Kaplan. "The Cys-Rich Region of Hepatitis A Virus Cellular Receptor 1 Is Required for Binding of Hepatitis A Virus and Protective Monoclonal Antibody 190/4." Journal of Virology 72, no. 5 (1998): 3751–61. http://dx.doi.org/10.1128/jvi.72.5.3751-3761.1998.
Full textWeinberger, P., P. Kountourakis, C. Sasaki, et al. "Oropharyngeal squamous cell cancers (OSCC) bearing transcriptionally active human papillomavirus (HPV) display distinct protein expression profile." Journal of Clinical Oncology 24, no. 18_suppl (2006): 10028. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10028.
Full textSingh, Amareshwar T. K., Mistuni Ghosh, C. Shad Thaxton, Trudy M. Forte, Robert O. Ryan, and Leo I. Gordon. "The Bioactive Polyphenol Curcumin (diferuloylmethane) In Human Apolipoprotein A-1 Nanodisks Enhances Apoptosis and G1 Cell Cycle Arrest In Mantle Cell Lymphoma Compared with Free Curcumin." Blood 116, no. 21 (2010): 3934. http://dx.doi.org/10.1182/blood.v116.21.3934.3934.
Full textKlasa, Richard J., Alan F. List, and Bruce D. Cheson. "Rational Approaches to Design of Therapeutics Targeting Molecular Markers." Hematology 2001, no. 1 (2001): 443–62. http://dx.doi.org/10.1182/asheducation-2001.1.443.
Full textSchroeder, Frederick A., Krista L. Penta, Anouch Matevossian, et al. "Drug-Induced Activation of Dopamine D1 Receptor Signaling and Inhibition of Class I/II Histone Deacetylase Induce Chromatin Remodeling in Reward Circuitry and Modulate Cocaine-Related Behaviors." Neuropsychopharmacology 33, no. 12 (2008): 2981–92. http://dx.doi.org/10.1038/npp.2008.15.
Full textAiello, Aurora, Giuseppe Pandini, Francesco Frasca та ін. "Peroxisomal Proliferator-Activated Receptor-γ Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells". Endocrinology 147, № 9 (2006): 4463–75. http://dx.doi.org/10.1210/en.2005-1610.
Full textBäsecke, Jörg, Anneke Lehmann, Ulla Bergholz та ін. "The Glycogensynthase Kinase 3b (GSK-3β) Is Involved in Leukemic Transformation". Blood 112, № 11 (2008): 4489. http://dx.doi.org/10.1182/blood.v112.11.4489.4489.
Full textWang, Qinghua, Jing Tang, Shujun Jiang та ін. "Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1". Journal of Endocrinology 239, № 2 (2018): 167–80. http://dx.doi.org/10.1530/joe-18-0349.
Full textZhou, Yixin, Linhua Jin, Stefania Pittaluga, Mark Raffeld, Takashi Miida, and Yoko Tabe. "PI3K a Selective Inhibitor Induces Growth Inhibition In Mantle Cell Lymphoma." Blood 116, no. 21 (2010): 1812. http://dx.doi.org/10.1182/blood.v116.21.1812.1812.
Full textSlater, Alexandre, Ying Di, Joanne C. Clark, et al. "Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer." Blood 137, no. 24 (2021): 3443–53. http://dx.doi.org/10.1182/blood.2020009440.
Full textSloand, Elaine M., Katayoun Rezvani, Agnes Yong, et al. "Cytotoxic CD8 T Cell Immune Responses to Wilms Tumor Protein (WT-1) Characterizes Immunosuppression-Responsive Myelodysplasia (MDS)." Blood 108, no. 11 (2006): 849. http://dx.doi.org/10.1182/blood.v108.11.849.849.
Full textMalkovsky, M., D. G. McNeel, M. Wallace та ін. "Use of zoledronic acid (ZA) and interleukin-2 (IL-2) to activate and expand Vγ9Vδ2 T cells for therapeutic use in patients with metastatic renal cell carcinoma (mRCC)". Journal of Clinical Oncology 24, № 18_suppl (2006): 14607. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.14607.
Full textCichocki, Frank M., Todd Lenvik, Stephen K. Anderson, and Jeffrey S. Miller. "STAT5A Overexpression Enhances Killer Immunoglobulin Receptor (KIR) Expression in Developing NK Cells and Is Associated with a Loss of Reverse Transcription from the Proximal KIR Promoter." Blood 110, no. 11 (2007): 798. http://dx.doi.org/10.1182/blood.v110.11.798.798.
Full textDuhoux, Francois P., Agnes Jager, Luc Dirix, et al. "Combination of paclitaxel and LAG3-Ig (IMP321), a novel MHC class II agonist, as a first-line chemoimmunotherapy in patients with metastatic breast carcinoma (MBC): Interim results from the run-in phase of a placebo controlled randomized phase II." Journal of Clinical Oncology 35, no. 15_suppl (2017): 1062. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1062.
Full textMeachem, Sarah J., Saleela M. Ruwanpura, Jessica Ziolkowski, Jacquelyn M. Ague, Michael K. Skinner, and Kate L. Loveland. "Developmentally distinct in vivo effects of FSH on proliferation and apoptosis during testis maturation." Journal of Endocrinology 186, no. 3 (2005): 429–46. http://dx.doi.org/10.1677/joe.1.06121.
Full textSloand, Elaine M., Katayoun Rezvani, John Barrett, et al. "Myelodysplasia with Trisomy 8 Is Associated with a Cytotoxic CD8 T Cell Immune Response to Wilms Tumor-1 Protein (WT1)." Blood 104, no. 11 (2004): 474. http://dx.doi.org/10.1182/blood.v104.11.474.474.
Full textMoratalla, Rosario, Mario Vallejo, Bulent Elibol, and Ann M. Graybiel. "D1-class dopamine receptors influence cocaine-induced persistent expression of Fos-related proteins in striatum." NeuroReport 8, no. 1 (1996): 1–5. http://dx.doi.org/10.1097/00001756-199612200-00001.
Full textSmith, Porsha L., Fengting Yan, John T. Patton, et al. "PRMT5 Transgenic Mice Develop Aggressive Lymphoblastic Lymphomas." Blood 128, no. 22 (2016): 2936. http://dx.doi.org/10.1182/blood.v128.22.2936.2936.
Full textVanover, Kimberly, Steven Glass, Susan Kozauer, et al. "30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study." CNS Spectrums 24, no. 1 (2019): 190–91. http://dx.doi.org/10.1017/s1092852919000245.
Full textKapuria, Vaibhav, Geoffrey Bartholomeusz, Ling-Yuan Kong, et al. "A Novel Small-Molecule Approach To Inhibit Jak2 Tyrosine Kinase Signaling." Blood 110, no. 11 (2007): 1556. http://dx.doi.org/10.1182/blood.v110.11.1556.1556.
Full text